Search

Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.

Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.

Learn more about Ken Manotti, who leads philanthropic fundraising efforts at Memorial Sloan Kettering Cancer Center, where he is a Senior Vice President and Chief Development Officer.

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.

If you think women are the only people who get cancers caused by the human papillomavirus (HPV), think again. These cancers are on the rise in men.

Dr. Mao leads a team of integrative medicine specialists who offer complementary therapies such as massage and acupuncture to patients and caregivers.

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal residual disease (MRD) responses compared to VRd alone in patients with newly diagnosed, transplant-ineligible multiple myeloma.

Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Residents from communities across northern New Jersey and southern New York State will have easier access to MSK’s unique expertise when MSK Bergen becomes fully operational in winter 2017.